Literature DB >> 11434670

Multiple intracranial recurrent tumors with hyperprolactinemia combined with a parasellar malignant fibrous histiocytoma long after transfrontal surgery and irradiation to a pituitary adenoma.

M Fujikawa1, K Okamura, K Sato, M Shiratsuchi, T Yao, T Mizokami, M Fujishima.   

Abstract

We herein describe a 40-year-old woman with hyperprolactinemia, an empty sella and two extrasellar intracranial recurrent tumors which were revealed 23 years after the first transfrontal craniotomy and 18 years after the second transfrontal surgery and irradiation to a provable prolactin-producing pituitary macroadenoma. One recurrent tumor was in the right orbital apex causing right oculomotor nerve palsy, and the other tumor was in the right apex partispetrosae and foramen jugulare. Although her serum prolactin level decreased after the administration of bromocriptine mesilate, and the size of the two tumors remained unchanged, a malignant fibrous histiocytoma, which might have been induced by the irradiation 18 years before, grew rapidly in the right suprasellar-prepontine cistern to the right pedunculus cerebralis, leading to a poor prognosis. This case confirmed the importance of the life-lasting follow-up of pituitary adenomas treated with surgery and/or irradiation therapy. Not only ectopic recurrence of the primary tumor but also post-irradiation tumors may become apparent long after the removal of the primary tumor.

Entities:  

Mesh:

Year:  2001        PMID: 11434670     DOI: 10.1007/BF03351046

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  21 in total

Review 1.  Radiation oncogenesis in relation to the treatment of pituitary tumours.

Authors:  A Jones
Journal:  Clin Endocrinol (Oxf)       Date:  1991-11       Impact factor: 3.478

Review 2.  The MEN II syndromes and the role of the ret proto-oncogene.

Authors:  B A Ponder; D Smith
Journal:  Adv Cancer Res       Date:  1996       Impact factor: 6.242

3.  Prolactinomas express human heparin-binding secretory transforming gene (hst) protein product: marker of tumour invasiveness.

Authors:  I Shimon; D R Hinton; M H Weiss; S Melmed
Journal:  Clin Endocrinol (Oxf)       Date:  1998-01       Impact factor: 3.478

4.  Multiple intracranial metastases from a prolactin secreting pituitary tumour.

Authors:  R W Gasser; G Finkenstedt; F Skrabal; K Twerdy; V Grunert; U Mayr; H Frommhold; D Zur Nedden; J Feichtinger; F Hofstaedter
Journal:  Clin Endocrinol (Oxf)       Date:  1985-01       Impact factor: 3.478

5.  Intracranial dissemination of a macroprolactinoma.

Authors:  J Assies; N P Verhoeff; D A Bosch; L J Hofland
Journal:  Clin Endocrinol (Oxf)       Date:  1993-05       Impact factor: 3.478

6.  Transforming DNA sequences present in human prolactin-secreting pituitary tumors.

Authors:  R Gonsky; V Herman; S Melmed; J Fagin
Journal:  Mol Endocrinol       Date:  1991-11

7.  Malignant prolactinoma with extracranial metastases: a report of three cases.

Authors:  J D Walker; A Grossman; J V Anderson; E Ur; P J Trainer; J Benn; C Lowy; P H Sönksen; P N Plowman; D G Lowe
Journal:  Clin Endocrinol (Oxf)       Date:  1993-04       Impact factor: 3.478

Review 8.  Malignant prolactinomas.

Authors:  E A Popovic; J R Vattuone; K H Siu; I Busmanis; M J Pullar; J Dowling
Journal:  Neurosurgery       Date:  1991-07       Impact factor: 4.654

9.  Ras mutations in human pituitary tumors.

Authors:  H J Karga; J M Alexander; E T Hedley-Whyte; A Klibanski; J L Jameson
Journal:  J Clin Endocrinol Metab       Date:  1992-04       Impact factor: 5.958

10.  Prolactin cell carcinoma of the pituitary. Clinicopathologic, immunohistochemical, and ultrastructural study of a case with cranial and extracranial metastases.

Authors:  B W Scheithauer; R V Randall; E R Laws; K T Kovacs; E Horvath; M D Whitaker
Journal:  Cancer       Date:  1985-02-01       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.